The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| CHINA BIOLOGIC PRODS INC | COM | 16938C106 | 618 | 5,744 | SH | DFND | 1 | 5,744 | 0 | 0 | |
| ICICI BK LTD | ADR | 45104G104 | 432 | 57,641 | SH | DFND | 1 | 57,641 | 0 | 0 | |
| ISHARES TR | MSCI INDIA ETF | 46429B598 | 2,269 | 84,650 | SH | DFND | 1 | 84,650 | 0 | 0 | |
| MAKEMYTRIP LIMITED MAURITIUS | SHS | V5633W109 | 400 | 18,000 | SH | DFND | 1 | 18,000 | 0 | 0 | |